Loading...
XHKG
9955
Market cap103mUSD
Oct 28, Last price  
1.24HKD
1D
-0.80%
1Q
-20.51%
IPO
-95.41%
Name

ClouDr Group Ltd

Chart & Performance

D1W1MN
XHKG:9955 chart
No data to show
P/E
P/S
0.21
EPS
Div Yield, %
Shrs. gr., 5y
0.43%
Rev. gr., 5y
46.08%
Revenues
3.49b
-5.49%
284,334,082524,438,000839,123,0001,756,731,0002,988,056,0003,690,536,0003,488,094,000
Net income
-516m
L+59.85%
-159,102,043-557,397,000-2,866,975,000-4,138,913,000-1,688,937,000-323,065,000-516,409,000
CFO
-148m
L+5.67%
-222,322,559-360,335,000-438,465,000-666,333,000-642,631,000-140,430,000-148,391,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
IPO date
Jul 06, 2022
Employees
1,489
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT